VanEck Associates
NTBL

VanEck Associates’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

VanEck Associates’s Portfolio NTBL Stock Details NTBL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-249
Closed -$14K – 848
2018
Q3 		$14K Buy
249
+14
+6% +$886 ﹤0.01% 784
2018
Q2 		$18K Buy
235
+145
+161% +$11.7K ﹤0.01% 841
2018
Q1 		$7K Buy
90
+6
+7% +$1.21K ﹤0.01% 740
2017
Q4 		$21K Sell
84
-99
-54% -$23K ﹤0.01% 712
2017
Q3 		$39K Buy
183
+8
+5% +$1.37K ﹤0.01% 718
2017
Q2 		$27K Buy
+175
New +$33.1K ﹤0.01% 730

Other funds holding NTBL

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

VanEck Associates's NTBL Position: Q4 2018 in Review

VanEck Associates sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2018, closing a stake of 249 shares — an estimated $14K sold.

VanEck Associates first reported a position in NTBL in Q2 2017 and held it in 6 quarters. The position peaked at $39K in Q3 2017. 26 funds tracked by Wall St. Rank hold NTBL as of Q4 2018.

  • VanEck Associates reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2018 after selling out during the quarter.
  • VanEck Associates sold 249 Notable Labs, Ltd. Ordinary Shares shares in Q4 2018, an estimated $14K.
  • VanEck Associates first reported a position in Notable Labs, Ltd. Ordinary Shares in Q2 2017 and held it in 6 quarters.
  • VanEck Associates's Notable Labs, Ltd. Ordinary Shares position peaked at $39K in Q3 2017.
  • 26 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2018.

Based on VanEck Associates's 13F filing for Q4 2018, filed 12 Feb 2019.